Latest News for: brca
Edit
New Hope For Crypto: Senators Introduce Blockchain Regulatory Certainty Act
NewsBTC 12 Jan 2026
In a major new development for the crypto industry, Senators Ron Wyden and Cynthia Lummis announced on Monday evening the introduction of a bipartisan, standalone version of the Blockchain Regulatory Certainty Act (BRCA) ... Main Highlights Of The BRCA.
Edit
858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, Platinum-Resistant Ovarian Cancer
Pharmiweb 08 Jan 2026
Edit
CHAMP1 complex promotes heterochromatin assembly and reduces replication stress
PNAS 02 Jan 2026
By depositing repressive histone marks, ... .
Edit
Cayton Goldrich Foundation $30M Gift Creates Cedars-Sinai BRCA Center (Cedars Sinai Medical Center)
Public Technologies 18 Dec 2025
Cedars-Sinai has received a $30 million gift from the Cayton Goldrich Family Foundation to establish the Cedars-Sinai Cayton BRCA Center, a first-of-its-kind in Southern California ... carry a BRCA mutation.
Edit
Women with BRCA mutations may be suffering unnecessarily due to ‘misinformation’ about treatment: study
New York Post 13 Dec 2025
Edit
Health Ministry confirms BRCA test fault isolated to two cases, nationwide review clear
The Jerusalem Post 12 Nov 2025
The Health Ministry has concluded its investigation into faulty cancer tests, confirming that only two women were affected by erroneous results ....
Edit
MID PENN BANK DONATES $100,000 TO PENN MEDICINE’S BASSER CENTER FOR BRCA (Mid Penn Bancorp Inc)
Public Technologies 10 Nov 2025
Edit
Health ministry investigates malfunction in BRCA screening test after false negative results
The Jerusalem Post 29 Oct 2025
Edit
Save Our Wallets: Bitcoiners Must Act To Defend Their Right To Transact
Bitcoin Magazine 23 Oct 2025
Edit
Men with BRCA gene mutations ‘should be given annual prostate cancer checks’
Belfast Telegraph 17 Oct 2025
.
Edit
Experts advocate annual prostate screenings for men with BRCA mutations
The Independent 17 Oct 2025
Edit
Johnson & Johnson receives U.S. FDA Priority Review for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) in BRCA-mutated metastatic castration-sensitive prostate cancer (Johnson & Johnson)
Public Technologies 16 Oct 2025- 1